DK0573462T3 - Fremgangsmåde til fremhævning af fordybninger i tabletter - Google Patents

Fremgangsmåde til fremhævning af fordybninger i tabletter

Info

Publication number
DK0573462T3
DK0573462T3 DK92904760.3T DK92904760T DK0573462T3 DK 0573462 T3 DK0573462 T3 DK 0573462T3 DK 92904760 T DK92904760 T DK 92904760T DK 0573462 T3 DK0573462 T3 DK 0573462T3
Authority
DK
Denmark
Prior art keywords
tablets
highlighting
indentations
solvent
filling material
Prior art date
Application number
DK92904760.3T
Other languages
Danish (da)
English (en)
Inventor
Paul M V Gilis
Conde Valentin F V De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0573462T3 publication Critical patent/DK0573462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Paper (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Color Printing (AREA)
DK92904760.3T 1991-02-27 1992-02-14 Fremgangsmåde til fremhævning af fordybninger i tabletter DK0573462T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200417 1991-02-27

Publications (1)

Publication Number Publication Date
DK0573462T3 true DK0573462T3 (da) 1996-11-11

Family

ID=8207528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904760.3T DK0573462T3 (da) 1991-02-27 1992-02-14 Fremgangsmåde til fremhævning af fordybninger i tabletter

Country Status (16)

Country Link
US (1) US5405642A (de)
EP (2) EP0573462B1 (de)
JP (1) JP3237758B2 (de)
AT (1) ATE143259T1 (de)
AU (1) AU1260392A (de)
CA (1) CA2104096C (de)
DE (1) DE69214130T2 (de)
DK (1) DK0573462T3 (de)
ES (1) ES2094902T3 (de)
GR (1) GR3021929T3 (de)
IE (1) IE75729B1 (de)
MX (1) MX9200831A (de)
NZ (1) NZ241613A (de)
TW (1) TW201697B (de)
WO (1) WO1992015288A1 (de)
ZA (1) ZA921428B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
DE69702985T2 (de) 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
US6685961B1 (en) 2000-10-24 2004-02-03 Banner Pharmacaps, Inc. Colored gelatin-based formulations and method
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
CA2447984A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
MXPA04012555A (es) * 2002-06-26 2005-04-19 Mars Inc Tintas para comestibles para impresion por inyeccion de tinta (ink-jet) en substratos de comestibles.
US7029112B2 (en) 2002-08-05 2006-04-18 Mars, Incorporated Ink-jet printing on surface modified edibles and products made
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
RU2343174C2 (ru) * 2003-03-07 2009-01-10 Марс, Инкорпорейтед Водные чернила для печати на кондитерских изделиях
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
CA2563743A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
WO2006096435A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2006119884A2 (en) * 2005-05-06 2006-11-16 Boehringer Ingelheim International Gmbh Method for the treatment of drug abuse with flibanserin
JP2008540673A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤誘発性性機能不全の治療方法
US20060264512A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunction due to medical conditions
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
US7827911B2 (en) * 2005-09-22 2010-11-09 Bpsi Holdings, Inc. Method for printing on tablets
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
BRPI0712039A2 (pt) * 2006-05-09 2011-12-20 Boehringer Ingelheim Int uso de flibanserina para o tratamento de distúrbios de desejo sexual pós-menopausa
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
EP2043648A1 (de) * 2006-07-14 2009-04-08 Boehringer Ingelheim International GmbH Verwendung von flibanserin zur behandlung von sexualstörungen bei frauen
BRPI0716439B8 (pt) * 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
BRPI0716436B8 (pt) * 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US3436453A (en) * 1963-06-14 1969-04-01 American Cyanamid Co Surface dyed edible gelatin capsule with pigment marking
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
IN158328B (de) * 1981-03-09 1986-10-18 Ici Plc
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
JPS58192819A (ja) * 1982-05-04 1983-11-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤の製法
KR840000624A (ko) * 1982-06-02 1984-02-25 원본미기재 부식억제 페인트 조성물
DE3373624D1 (en) * 1982-06-10 1987-10-22 Ici Plc Manufacture of highlighted intagliated articles
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
FR2548675B1 (fr) * 1983-07-06 1987-01-09 Seppic Sa Compositions filmogenes pour enrobage des formes solides de produits pharmaceutiques ou alimentaires et produits obtenus revetus desdites compositions
US5006362A (en) * 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet

Also Published As

Publication number Publication date
DE69214130T2 (de) 1997-02-06
ATE143259T1 (de) 1996-10-15
TW201697B (de) 1993-03-11
ES2094902T3 (es) 1997-02-01
IE920611A1 (en) 1992-09-09
MX9200831A (es) 1992-08-01
IE75729B1 (en) 1997-09-24
WO1992015288A1 (en) 1992-09-17
AU1260392A (en) 1992-10-06
DE69214130D1 (de) 1996-10-31
NZ241613A (en) 1993-06-25
ZA921428B (en) 1993-08-26
CA2104096C (en) 2003-06-10
EP0501553A1 (de) 1992-09-02
EP0573462B1 (de) 1996-09-25
JP3237758B2 (ja) 2001-12-10
GR3021929T3 (en) 1997-03-31
CA2104096A1 (en) 1992-08-28
JPH06504935A (ja) 1994-06-09
EP0573462A1 (de) 1993-12-15
US5405642A (en) 1995-04-11

Similar Documents

Publication Publication Date Title
NZ241613A (en) Highlighting intagliations in tablets
DE69012545D1 (de) Farbauftraggerät.
DE68912785D1 (de) Farbbeschichteter artikel.
FI933219A7 (fi) Menetelmä käsittelyajan pidentämiseksi vesiliukoisella päällystekoostumuksella
DE69402799D1 (de) Anwuchsverhindernde Überzugszusammensetzung
DE69201797D1 (de) Strukturierter träger und verfahren zu seiner herstellung.
DE68916996D1 (de) Anwuchsverhindernde Überzugszusammensetzung.
DE69105078D1 (de) Beschichtungszusammensetzung und damit beschichteter Kunststoffgegenstand.
DE69011151D1 (de) Ultraviolettunterdrückte Lichtquelle, dafür verwendeter Beschichtungsstoff und Verfahren zu seiner Herstellung.
DE69005926D1 (de) Verfahren zum Beschichten von Titandioxidpigmenten.
FI922555A7 (fi) Belaeggning av papper.
DE69429088D1 (de) Farbspritzanlage
DE69103218D1 (de) Farbspritzanlage mit kontrolliertem Durchfluss.
DE69203574D1 (de) Beschichtungszusammensetzung.
DK0738309T3 (da) Optisk klar, hydrofob overtrækssammensætning
NO913110D0 (no) Beleggmateriale.
DE69214249D1 (de) Polypropylenharz-zusammensetzung, verfahren zur beschichtung von daraus hergestellten geformten gegenständen und so beschichtete geformte gegenstände
DE59100238D1 (de) Verfahren zum beschichten von schaufeln.
EP0677456A4 (de) Beschichtungsbehälter.
DE69124851D1 (de) Zusammensetzungen zum Beschichten von Glasbehältern
DE69005577D1 (de) Farbsprühvorrichtung.
DE69101381D1 (de) Einrichtung zum anlegen von prothesen.
EP0589710A3 (de) Vorrichtung zur Herstellung von Schablonen.
DE69003621D1 (de) Farbspritzanlage mit kontrolliertem durchfluss.
ATE112585T1 (de) Zusammensetzung zur entfernung von polymerüberzügen.